Healthcare around the world depends on the production of pure biopharmaceuticals. To be effective, those purification processes must be fast, robust, and affordable. By using non-affinity-based ...
Downstream sample preparation for subsequent quality attribute analysis represents “a significant bottleneck in process development for non-antibody biologics,” wrote Kevin Brower, PhD, global head of ...
WALTHAM, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...
WALTHAM, Mass. and HALLE (Saale), Germany, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo ...
In search of the next generation chromatographic technique for antibody purification, our team has developed an affinity chromatography method using the unconventional nucleotide binding site (NBS).
Affinity chromatography theoretically does just that—a ligand that specifically interacts with the target protein is immobilized on a chromatography matrix; the target protein binds to the column, and ...
Biopharmaceutical CDMO Fujifilm Biotechnologies has unveiled its ShunzymeX precision purification technology, which simplifies downstream processing for complex biologics. “Together, we believe this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results